These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34508550)

  • 1. Cardiovascular disease in psoriatic arthritis: facts and unmet needs.
    Gialouri CG; Fragoulis GE
    Rheumatology (Oxford); 2022 Apr; 61(4):1305-1306. PubMed ID: 34508550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular risk factors in psoriatic and rheumatoid arthritis].
    Rebrov AP; Nikitina NM; Gaĭdukova IZ
    Ter Arkh; 2011; 83(5):20-4. PubMed ID: 21780652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation?
    Kristensen SL; McInnes IB; Sattar N
    Ann Rheum Dis; 2015 Feb; 74(2):321-2. PubMed ID: 25429028
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis.
    Jamnitski A; Visman IM; Peters MJ; Boers M; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2011 May; 70(5):875-6. PubMed ID: 20956406
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis.
    Eder L; Dey A; Joshi AA; Boehncke WH; Mehta NN; Szentpetery A
    J Rheumatol Suppl; 2019 Jun; 95():20-27. PubMed ID: 31154400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis.
    Liew JW; Ramiro S; Gensler LS
    Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):369-389. PubMed ID: 31171309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis.
    Navarini L; Sperti M; Currado D; Costa L; Deriu MA; Margiotta DPE; Tasso M; Scarpa R; Afeltra A; Caso F
    Rheumatology (Oxford); 2020 Jul; 59(7):1767-1769. PubMed ID: 31990342
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.
    Peluso R; Caso F; Tasso M; Ambrosino P; Dario Di Minno MN; Lupoli R; Criscuolo L; Caso P; Ursini F; Puente AD; Scarpa R; Costa On Behalf Of CaRRDs Study Group L
    Rev Recent Clin Trials; 2018; 13(3):199-209. PubMed ID: 29542417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
    Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis.
    Lucke M; Messner W; Kim ES; Husni ME
    Arthritis Res Ther; 2016 Aug; 18():178. PubMed ID: 27485213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualifying unmet needs and improving standards of care in psoriatic arthritis.
    Helliwell P; Coates L; Chandran V; Gladman D; de Wit M; FitzGerald O; Kavanaugh A; Strand V; Mease PJ; Boehncke WH; Langley RG; Lubrano E; Maccarone M; Schulze-Koops H; Miceli-Richard C; Queiro R
    Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1759-66. PubMed ID: 25047391
    [No Abstract]   [Full Text] [Related]  

  • 12. Health professional views on the assessment and management of foot problems in people with psoriatic arthritis in Australia and New Zealand: a qualitative investigation.
    Carter K; Walmsley S; Rome K; Turner DE
    BMC Musculoskelet Disord; 2019 May; 20(1):191. PubMed ID: 31054575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis.
    Eder L; Wu Y; Chandran V; Cook R; Gladman DD
    Ann Rheum Dis; 2016 Sep; 75(9):1680-6. PubMed ID: 26493817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
    Nissen CB; Hørslev-Petersen K; Primdahl J
    Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts and unmet needs in psoriatic arthritis.
    Mahmood F; Coates LC; Helliwell PS
    Clin Rheumatol; 2018 Feb; 37(2):297-305. PubMed ID: 29134513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives of patients and health professionals on the experience of living with psoriatic arthritis-related foot problems: a qualitative investigation.
    Carter K; Walmsley S; Chessman D; Rome K; Turner DE
    Clin Rheumatol; 2019 Jun; 38(6):1605-1613. PubMed ID: 30617439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular risk in psoriatic arthritis].
    Badokin VV; Ianysheva AV; Aleksandrova EN; Mach ES; Popkova TV
    Ter Arkh; 2009; 81(6):41-7. PubMed ID: 19663192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with high cardiovascular risk in psoriatic arthritis and non-psoriatic spondyloarthritis.
    Kavadichanda C; Shanoj KC; Ganapathy S; Shah SI; Ananthakrishnan R; Sahoo J; Negi VS
    Rheumatol Int; 2022 Feb; 42(2):251-260. PubMed ID: 35031846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.
    Johnsson H; McInnes IB; Sattar N
    Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.